DNVYX
Price
$28.25
Change
-$0.22 (-0.77%)
Updated
Aug 15 closing price
Net Assets
6.68B
VIVIX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

DNVYX vs VIVIX

Header iconDNVYX vs VIVIX Comparison
Open Charts DNVYX vs VIVIXBanner chart's image
Davis NY Venture Y
Price$28.25
Change-$0.22 (-0.77%)
VolumeN/A
Net Assets6.68B
Vanguard Value Index I
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
DNVYX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNVYX vs. VIVIX commentary
Aug 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNVYX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. DNVYX (6.68B). VIVIX pays higher dividends than DNVYX: VIVIX (2.19) vs DNVYX (1.73). DNVYX was incepted earlier than VIVIX: DNVYX (29 years) vs VIVIX (27 years). DNVYX (0.67) is less costly to investors than VIVIX (0.04). DNVYX is a more actively managed with annual turnover of: 17.00 vs. VIVIX (9.00). DNVYX (5000000) and VIVIX (5000000) have matching initial minimum investment requirements. VIVIX annual gain was more profitable for investors over the last year : 7.91 vs. DNVYX (-1.31). VIVIX return over 5 years is better than : 68.54 vs. DNVYX (4.61).
DNVYXVIVIXDNVYX / VIVIX
Total Expense Ratio0.670.041,675%
Annual Report Gross Expense Ratio0.670.041,675%
Fund Existence29 years27 years-
Gain YTD5.6126.53386%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets6.68B196B3%
Annual Yield % from dividends1.732.1979%
Returns for 1 year-1.317.91-17%
Returns for 3 years18.3925.9371%
Returns for 5 years4.6168.547%
Returns for 10 years-13.51114.61-12%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLHIX27.290.35
+1.30%
Virtus KAR Health Sciences Inst
PABGX203.64-0.19
-0.09%
T. Rowe Price Blue Chip Growth Advisor
IUTCX28.21-0.14
-0.49%
Invesco Dividend Income C
AMFEX19.64-0.11
-0.56%
AAMA Equity
GSMCX38.41-0.23
-0.60%
Goldman Sachs Mid Cap Value Instl